AXGN Q4 2017 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+48.8% YoY

Gross Profit

$14M84.6% margin

Operating Income

-$2M-10.6% margin

Net Income

-$2M-14.7% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$59M

Total Liabilities

$34M

Stockholders' Equity

$25M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$11M	+48.8%
Gross Profit	$14M	$10M	+49.9%
Operating Income	-$2M	-$3M	+33.5%
Net Income	-$2M	-$6M	+55.6%